Incyte Corp. (INCY)
122.83
-0.45
(-0.37%)
USD |
NASDAQ |
Sep 11, 13:46
Incyte Gross Profit (TTM) : 5.320B for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.320B |
| March 31, 2026 | 4.890B |
| December 31, 2025 | 4.703B |
| September 30, 2025 | 4.407B |
| June 30, 2025 | 4.192B |
| March 31, 2025 | 4.023B |
| December 31, 2024 | 3.864B |
| September 30, 2024 | 3.717B |
| June 30, 2024 | 3.525B |
| March 31, 2024 | 3.446B |
| December 31, 2023 | 3.380B |
| September 30, 2023 | 3.308B |
| June 30, 2023 | 3.222B |
| March 31, 2023 | 3.200B |
| December 31, 2022 | 3.141B |
| September 30, 2022 | 3.096B |
| June 30, 2022 | 3.103B |
| March 31, 2022 | 2.912B |
| December 31, 2021 | 2.799B |
| September 30, 2021 | 2.735B |
| June 30, 2021 | 2.550B |
| March 31, 2021 | 2.539B |
| December 31, 2020 | 2.505B |
| September 30, 2020 | 2.299B |
| June 30, 2020 | 2.233B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.078B |
| December 31, 2019 | 2.011B |
| September 30, 2019 | 1.965B |
| June 30, 2019 | 1.869B |
| March 31, 2019 | 1.865B |
| December 31, 2018 | 1.754B |
| September 30, 2018 | 1.675B |
| June 30, 2018 | 1.612B |
| March 31, 2018 | 1.423B |
| December 31, 2017 | 1.426B |
| September 30, 2017 | 1.310B |
| June 30, 2017 | 1.206B |
| March 31, 2017 | 1.134B |
| December 31, 2016 | 1.027B |
| September 30, 2016 | 957.56M |
| June 30, 2016 | 882.28M |
| March 31, 2016 | 805.88M |
| December 31, 2015 | 698.42M |
| September 30, 2015 | 578.87M |
| June 30, 2015 | 592.94M |
| March 31, 2015 | 531.54M |
| December 31, 2014 | 467.08M |
| September 30, 2014 | 445.81M |
| June 30, 2014 | 338.15M |
| March 31, 2014 | 341.92M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Mirum Pharmaceuticals, Inc. | 504.67M |
| Regeneron Pharmaceuticals, Inc. | 12.65B |
| Eli Lilly & Co. | 66.44B |
| AbbVie, Inc. | 45.98B |
| Biogen, Inc. | 6.211B |